ZyVersa Therapeutics’ CEO, Stephen C. Glover, to Participate in the 2024 BIO International Convention

May 14, 2024

https://www.globenewswire.com/news-release/2024/05/14/2881298/0/en/ZyVersa-Therapeutics-CEO-Stephen-C-Glover-to-Participate-in-the-2024-BIO-International-Convention.html

WESTON, Fla., May 14, 2024 (GLOBE NEWSWIRE) — ZyVersa Therapeutics, Inc. (Nasdaq:ZVSA, or “ZyVersa”), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for the treatment of renal and inflammatory diseases with high unmet medical needs, announces that Stephen C. Glover, Co-Founder, Chairman, Chief Executive Officer, and President, will participate in the 2024 BIO International Convention being held June 3 – 6, 2024 in San Diego, California.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.